BOARD OBSERVER AND DIRECTOR NOMINATION AGREEMENTBoard Observer and Director Nomination Agreement • October 17th, 2018 • Marker Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 17th, 2018 Company Industry JurisdictionTHIS BOARD OBSERVER AND DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made as of October 17, 2018 (the “Effective Date”), between MARKER THERAPEUTICS, INC., a Delaware corporation formerly known as TapImmune Inc., a Nevada corporation (the “Company”), and NEW ENTERPRISE ASSOCIATES, INC. (the “Shareholder”). Unless otherwise specified herein, all of the capitalized terms used herein are defined in Section 3 hereof.